Time trends in the use of β-blockers and other pharmacotherapies in older adults with congestive heart failure
- 31 October 2004
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 148 (4), 710-717
- https://doi.org/10.1016/j.ahj.2004.04.002
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Lifetime Risk for Developing Congestive Heart FailureCirculation, 2002
- Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trialsJournal of the American College of Cardiology, 2002
- β-Blockers in Congestive Heart Failure: A Bayesian Meta-AnalysisAnnals of Internal Medicine, 2001
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997
- Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart FailureJAMA, 1995
- Recruitment of adults 65 years and older as participants in the cardiovascular health studyAnnals of Epidemiology, 1993
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- The cardiovascular health study: Design and rationaleAnnals of Epidemiology, 1991
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986